Histological features and severity of oxaliplatin-induced liver injury and clinical associations

Ilke Nalbantoglu, Benjamin R. Tan, David C. Linehan, Feng Gao, Elizabeth M. Brunt

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Objective: Oxaliplatin, a component of chemotherapy for colorectal carcinoma liver metastases, can result in hepatic sinusoidal injury; rarely, the injury is fatal. The manifestations of injury are variable. There are no known predictors of susceptibility and outcome. A semi-quantitative system for assessing histological features in non-tumor liver was designed to compare with clinical short-term and long-term outcomes. Methods: A review of 47 patients with metastatic colorectal carcinoma who received liver resection utilizing a system for an aggregate liver injury score (0-4) included hepatocellular and sinusoidal features. Immunohistochemistry (IHC) for aberrant capillarization was included. The proliferation of hepatocytes and sinusoidal lining cells was evaluated with Ki-67 stain. Results: In total, 32 (68.1%) cases showed light microscopic lesions of oxaliplatin-induced liver injury, in which 26 were moderate to severe. Elevated preoperative aspartate aminotransferase (AST) and alkaline phosphatase levels were noted with higher injury scores (P=0.01). Patients with higher injury scores had no significant increase in short-term postoperative complications, with one notable exception, who died of liver failure 10 months postoperatively. Increased CD34 expression was associated with higher injury scores (P=0.00004), and abnormal AST levels (P=0.04). Preoperative use of bevacizumab was not associated with lower injury scores. Steatosis was correlated with body mass index (P=0.052) but not with exposure to oxaliplatin, bevacizumab or irinotecan. Conclusions: The proposed liver injury scoring system encompasses the spectrum of sinusoidal and hepatocellular lesions in oxaliplatin-induced liver injury and is correlated with serum liver enzyme levels in this group. Most patients recovered without complications during the 93-month follow-up, indicating that these lesions are reversible.

Original languageEnglish
Pages (from-to)553-560
Number of pages8
JournalJournal of Digestive Diseases
Volume15
Issue number10
DOIs
StatePublished - Oct 1 2014

Keywords

  • Liver sinusoid
  • Oxaliplatin
  • Scoring

Fingerprint

Dive into the research topics of 'Histological features and severity of oxaliplatin-induced liver injury and clinical associations'. Together they form a unique fingerprint.

Cite this